GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Neogen Chemicals Ltd

Neogen Chemicals Q2 FY27 Consolidated PAT Surges 144% to INR 8 crore

RESULTS ▲ Positive Development MEDIUM RISK
📅 Filed on BSE: 01 Nov 2026, 11:27 PM IST  ·  BSE ID: 66ad99d4-738d-4254-bfd9-6863354f3b26
View Original BSE Filing (PDF)
💡
In Simple Terms
Neogen Chemicals reported strong Q2 results, with profit more than doubling, driven by growth in its core business and new battery chemicals segment.
🤖 AI Summary
  • Consolidated revenue for Q2 FY27 increased 42% YoY to INR 296.0 crore.
  • Consolidated Profit After Tax (PAT) for Q2 FY27 rose 144% YoY to INR 8.2 crore.
  • Battery Chemicals division, Neogen Ionics, achieved Q2 FY27 revenue of INR 37 crore, up from INR 5.4 crore in Q2 FY26.
  • Organolithium manufacturing facility expansion approved to 600 MTPA with an investment of up to INR 45 crore.
  • Total on-account insurance claims received/receivable related to an earlier event stand at INR 316 crore.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Consolidated Revenue (Q2 FY27)
296.0 INR in crore
42%
Consolidated Profit After Tax (Q2 FY27)
8.2 INR in crore
144%
Battery Chemicals Revenue (Q2 FY27)
37 INR in crore
Not comparable — limited prior period data.
Organolithium Expansion Investment
45 INR crore
Total On-Account Insurance Claim Received/Receivable
316 INR crore
Consolidated EBITDA (Q2 FY27)
45.3 INR in crore
51%
🏢 How This Affects the Company
📈
Business Impact
The growth in the Battery Chemicals division to INR 37 crore revenue for Q2 FY27 from INR 5.4 crore in Q2 FY26 indicates significant scaling in a new segment. The Organolithium expansion from 300 MTPA to 600 MTPA enhances manufacturing capacity for high-growth applications.
💰
Financial Impact
Consolidated Profit After Tax (PAT) increased 144% to INR 8.2 crore, while interest expenses rose 43% to INR 27.8 crore, impacting net profitability. Early repayment of NCDs using QIP proceeds is expected to reduce future interest costs.
⚙️
Operational Impact
The commissioning of an additional 1,000 MTPA for Lithium Electrolyte Salts and ongoing trial production for another 300 MTPA expands operational capabilities. Mechanical completion timelines for Electrolytes and Electrolyte Salts remain on schedule.
⚠️
Risk Impact
The acceptance of an additional insurance claim of INR 152 crore reduces financial uncertainty related to past events. Higher interest and depreciation costs from ongoing CAPEX initiatives are temporarily impacting profitability.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this earnings presentation.
👤
Who Is Affected
Shareholders are affected by the company's financial performance, with consolidated EPS of INR 2.96 in Q2 FY27 compared to INR 1.28 in Q2 FY26. The reclassification of debt due to QIP proceeds may impact future interest expenses.
🔍
Management Signal
Management is focusing on strategic growth through capacity expansion in Organolithium and Battery Chemicals, while actively resolving past financial setbacks via insurance claims and reducing debt through QIP proceeds.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q3 FY27 financial results — monitor sustained growth in Battery Chemicals segment.
Progress on Organolithium expansion — verify capacity increase to 600 MTPA.
Updates on remaining insurance claim payouts — confirm receipt of INR 152 crore.
MEDIUM RISK High interest costs from ongoing CAPEX and initial fixed-cost absorption in new divisions present short-term financial pressure.
💡 Investor Takeaway
Neogen Chemicals reported Q2 FY27 consolidated revenue of INR 296.0 crore, up 42% YoY, and consolidated PAT of INR 8.2 crore, up 144% YoY. The Battery Chemicals division's revenue reached INR 37 crore. Organolithium capacity expansion to 600 MTPA and INR 316 crore in insurance claims underscore ongoing strategic initiatives.
⚖️ Strengths & Concerns

✅ Positives

  • Consolidated Revenue grew 42% YoY to INR 296.0 crore in Q2 FY27, demonstrating sustained growth across segments.
  • Consolidated Profit After Tax (PAT) surged 144% YoY to INR 8.2 crore in Q2 FY27, reflecting improved operational performance.

⚠️ Concerns

  • Consolidated EBITDA Margin was 15.3% in Q2 FY27, slightly lower than Standalone EBITDA Margin of 18.6% for the same period.
  • Consolidated Interest expense increased 43% YoY to INR 27.8 crore in Q2 FY27, impacting overall profitability.
📅 Company Track Record
Neogen Chemicals reported Q1 FY27 consolidated net profit rise of 67% to INR 17.1 crore, following the completion of the Dahej plant reconstruction. The company approved a INR 600 crore fundraise and plans INR 45 crore Organo-Lithium expansion, along with early repayment of INR 200,00,00,000 NCDs.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Neogen Chemicals' consolidated revenue in Q2 FY27?
Neogen Chemicals reported a consolidated revenue of INR 296.0 crore in Q2 FY27, representing a 42% increase from Q2 FY26.
What was Neogen Chemicals' consolidated Profit After Tax (PAT) in Q2 FY27?
The consolidated Profit After Tax (PAT) for Neogen Chemicals in Q2 FY27 was INR 8.2 crore, a 144% increase compared to INR 3.4 crore in Q2 FY26.
How much revenue did the Battery Chemicals division generate in Q2 FY27?
The Battery Chemicals division, Neogen Ionics, generated INR 37 crore in revenue for Q2 FY27, an increase from INR 5.4 crore in Q2 FY26.
What is the planned investment for Organolithium facility expansion?
The board approved an expansion of the Organolithium facility at Patancheru from 300 MTPA to 600 MTPA with an estimated investment of up to INR 45 crore.
What is the status of Neogen Chemicals' insurance claims?
Total on-account insurance claims received/receivable for Neogen Chemicals stand at INR 316 crore, including an additional accepted claim amount of INR 152 crore.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.